Review the current Novo Nordisk AS ADR (NVO:XNYS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if NVO is the best investment for you.

Shares in Novo Nordisk fell as much as 3.5 per cent on Monday after detailed trial data on its experimental obesity drug CagriSema fueled investor concerns about its competitiveness against rival ...

Watch CTV News Toronto at Six, the GTHA’s most-watched evening newscast, for Toronto’s top stories, breaking news and in-depth coverage of local issues.